marijuana stocks

Nabis Holdings Completes Investments in Two Additional Municipally Approved Provisioning Centres – Battle Creek & Constantine, Michigan

Nabis Holdings (CSE:NAB; OTC: NABIF; FRA: 71P) (“Nabis” or the “Company”) is pleased to announce that it has completed its investments (“Investments”) in strategically located properties that have municipal approvals for provisioning centres in Battle Creek (“Battle Creek”) and Constantine (“Constantine”), both located in Michigan. The Company is currently targeting to complete three additional provisioning center acquisitions in the coming weeks, bringing the total to seven provisioning centers in Michigan. Nabis is currently evaluating ten to fifteen additional municipally-approved locations in Michigan which will substantially increase the Company’s overall presence in the U.S. cannabis space.

“We continue to cement our foundation in Michigan with the completion of our investments in the Battle Creek & Constantine provisioning centres. With additional provisioning centres, we believe Nabis is well positioned in the largest medical license cannabis market in the U.S.,” said Shay Shnet, CEO & Director of Nabis. “Our strategic plan to aggressively expand into many other limited license states remains the top priority for our team. The closing of these two investments mark another important milestone for Nabis, as we continue to successfully expand our presence nationwide.”

Pursuant to the investment agreements, the Company paid a combination of cash at closing and deferred cash for an undisclosed total amount. The Company will issue Finder fee shares subject to the board and CSE approval.

With the closing of the Investment, the Company is working to complete the remainder of its previously announced binding Letter of Intent (“LOI”) as it continues to grow its footprint as part of the Company’s U.S. cannabis strategy.

About Nabis Holdings

Nabis Holdings is a Canadian investment issuer that invests in high quality cash flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. Led by two of the co-founders of MPX Bioceutical, one of the largest takeovers in the U.S. Cannabis space to date, the company has a proven track record in emerging markets to create significant shareholder value. The Company is focused on investing across the entire vertically integrated aspects of the space with a focus on revenue generation, EBITDA and growth.

For more information, please visit

The CSE does not accept responsibility for the adequacy or accuracy of this release.
All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The risks are without limitations: that the acquisitions will be completed by the Company or completed upon the terms disclosed; the price for cannabis and related products will remain consistent and the consumer demand remains strong; availability of financing to the Company to develop the retail locations; retention of key employees and management; changes in State and/or municipal regulations of retail operations and changes in government regulations generally. Important factors that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission and the Alberta Securities Commission.


“Shay Shnet”

Shay Shnet
CEO and Director

For inquiries, please contact:

Company Contact:
PH: 604-687-7130

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
1 comment
Leave a Reply

Your email address will not be published.

You May Also Like

$CMM.V Announces New Partnership Agreement with Aviva Medical

Canabo Announces New Partnership Agreement with Aviva Medical Securing Additional Clinics and…

FDA Grants INSYS Therapeutics, Inc. (INSY) Fast Track’ Designation for (CBD) Oral Solution as Investigational Treatment

FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Cannabidiol (CBD) Oral Solution…

Verano Holdings Corp. (VRNOF) Announces First Quarter 2022 Financial Results

Verano Announces First Quarter 2022 Financial Results Verano Holdings Corp. (CSE: VRNO)…